Home

Tetracaine

Tetracaine

Specifications

94-24-6CAS Number
202-316-6EC Number
2-(dimethylamino)ethyl 4-(butylamino)benzoateIUPAC Name
C15H24N2O2Chemical Formula
264.36 g/molMolecular Weight
tetracaine; 94-24-6; Amethocaine; 2-(Dimethylamino)ethyl 4-(butylamino)benzoate; Laudocaine; Metraspray; Pontocaine; Anetain; Dicaine; Uromucaesthin; Contralgin; Fissucain; Intercain; Medicaine; Meethobalm; Mucaesthin; Niphanoid; Medihaler-Tetracaine; Tetracaina; Tetrakain; Dicain; Dikain; Tetracainum; 2-(Dimethylamino)ethyl p-(butylamino)benzoate; p-Butylaminobenzoyl-2-dimethylaminoethanol; Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester; Diaethylaminoaethanol ester der p-butylaminobenzoesaeure; CHEBI:9468; 0619F35CGV; DTXSID1043883; p-(butylamino)benzoic acid beta-(dimethylamino)ethyl ester; Tetracaine cream; FranklyNumb 3; Painless Tattoo 3; Burn Solution Cream; RefChem:56112; Numfast Tetracaine Green; Hydrochloride, Tetrracaine; BLT 3; DTXCID9023883; dicainum (for the hydrochloride); C05AD02; D04AB06; N01BA03; S01HA03; 202-316-6; Rexocaine; Dimethylaminoethyl p-butyl-aminobenzoate; 2-dimethylaminoethyl 4-(butylamino)benzoate; MFCD00053787; 4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester; Butylocaine; p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester; CHEMBL698; BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER; 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove; Tetrakain [Czech]; Tetracainum [INN-Latin]; Tetracaina [INN-Spanish]; benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester ,hydrochloride; Amethocaine (TN); Tetracaine (USP/INN); NCGC00016049-02; CAS-136-47-0; EINECS 202-316-6; BRN 2216051; Landocaine; Tetracain; Tetracaine [USP:INN:BAN]; UNII-0619F35CGV; Amethocaine HCl; Tetracaine CRS; 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]; Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]; TE4; Spectrum_001032; Pantocaine (Salt/Mix); TETRACAINE [INN]; Prestwick0_000571; Prestwick1_000571; Prestwick2_000571; Prestwick3_000571; Spectrum2_001328; Spectrum3_000562; Spectrum4_000351; Spectrum5_001072; Lopac-T-7508; TETRACAINE [VANDF]; Epitope ID:174843; TETRACAINE [MART.]; TETRACAINE [USP-RS]; TETRACAINE [WHO-DD]; Lopac0_001211; SCHEMBL34714; BSPBio_000382; BSPBio_001944; KBioGR_000781; KBioSS_001512; 4-14-00-01172 (Beilstein Handbook Reference); DivK1c_000607; SPBio_001455; SPBio_002601; BPBio1_000422; TETRACAINE [GREEN BOOK]; Tetracaine, >=98% (TLC); TETRACAINE [ORANGE BOOK]; KBio1_000607; KBio2_001512; KBio2_004080; KBio2_006648; KBio3_001444; TETRACAINE [EP MONOGRAPH]; NINDS_000607; SYNERA COMPONENT TETRACAINE; TETRACAINE [USP MONOGRAPH]; ALBB-025902; HY-A0079; MSK10139; BDBM50017659; EBC-12624; SBB058194; AKOS015889234; AC-3480; CCG-205285; DB09085; SDCCGSBI-0051178.P005; IDI1_000607; NCGC00016049-01; NCGC00016049-03; NCGC00016049-04; NCGC00016049-14; NCGC00162367-01; AS-81743; DA-78348; FT177996; ST099115; SY066710; SBI-0051178.P004; AB00053549; NS00008930; Tetracaine, meets USP testing specifications; .beta.-Dimethylaminoethyl p-butylaminobenzoate; C07526; D00551; 2-(Dimethylamino)ethyl 4-(butylamino)benzoate #; AB00053549-11; AB00053549_12; AB00053549_13; EN300-6748839; F375204; Q419608; aniline, N-butyl-4-(2-dimethylaminoethoxycarbonyl)-; BRD-K45071273-003-05-8; BRD-K45071273-003-15-7; BRD-K45071273-003-24-9; BRD-K45071273-003-25-6; Tetracaine, United States Pharmacopeia (USP) Reference Standard; BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE; InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3HSynonyms